Showing results (4421-4430 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|April 14, 2017
Herpes simplex virus type 1 abrogates the antiviral activity of Ch25h via its virion host shutoff proteinHongjuan You, Hui Yuan, Wenkun Fu, et al.Antiviral Research|January 1, 1991
The effect of HSV multiplication rate on antiviral drug efficacy in vitroJ M Upadhyay, J M Hill, M Jemison, et al.Antiviral Research|February 20, 2014
The beginning of the end: what is the future of interferon therapy for chronic hepatitis C?Jordan J FeldAntiviral Research|April 6, 2019
Cell line-dependent activation and antiviral activity of T-1105, the non-fluorinated analogue of T-705 (favipiravir)Johanna Huchting, Evelien Vanderlinden, Ria Van Berwaer, et al.Antiviral Research|April 6, 2019
New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidaseVimbaishe P Chibanga, Larissa Dirr, Patrice Guillon, et al.Antiviral Research|March 6, 2019
Characterization of Reston virus infection in ferretsFeihu Yan, Shihua He, Logan Banadyga, et al.Antiviral Research|July 15, 2019
The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitorsYu-Jin Kim, Beatrice Cubitt, Emily Chen, et al.Antiviral Research|August 30, 2022
Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19James F Demarest, Maryline Kienle, RuthMabel Boytz, et al.Antiviral Research|September 24, 2022
Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotavirusesYuanjun Zeng, Feibo Song, Guoxing Luo, et al.Antiviral Research|October 15, 2022
Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravirJonna B Westover, Shibani Naik, Kevin W Bailey, et al.Pageof 523